MktsMarkets

Vistagen Therapeutics, Inc.
NASDAQ: VTGNKey statistics
VTGN News
Stories mentioning VTGN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 13,158 | 14,223 | 15,915 | 11,678 | 10,207 | 11,305 | 10,215 | 7,648 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 17,187 | 19,849 | 20,311 | 16,048 | 14,480 | 15,354 | 14,410 | 12,215 |
| Operating Income (Loss) | (16,723) | (19,546) | (20,053) | (15,804) | (14,495) | (15,120) | (14,227) | (12,131) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 0.00 | 6.00 | (2.00) | 0.00 | 0.00 | 0.00 | ||
| Pretax Income | (16,267) | (18,899) | (19,417) | (15,095) | (13,635) | (14,089) | (12,954) | (10,733) |
| Tax Provision | 7.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.00 | 0.00 |
| Net Income (Loss) | (16,274) | (18,899) | (19,417) | (15,095) | (13,635) | (14,089) | (12,961) | (10,733) |
| Earnings Per Share (Basic) | (0.43) | (0.45) | (0.54) | (0.47) | (0.44) | (0.46) | (0.42) | (0.35) |
| Earnings Per Share (Diluted) | (0.43) | (0.45) | (0.54) | (0.47) | (0.44) | (0.46) | (0.42) | (0.35) |
| Weighted Average Shares Outstanding (Basic) | 38,074 | 42,234 | 35,749 | 31,931 | 30,877 | 30,712 | 30,632 | 30,603 |
| Weighted Average Shares Outstanding (Diluted) | 38,074 | 42,234 | 35,749 | 31,931 | 30,877 | 30,712 | 30,632 | 30,603 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VTGN
Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol VTGN. It last traded at $0.2000 (Nov 18, 2026, 4:00 PM ET), up 6.1% on the day. That gives Vistagen Therapeutics a market capitalisation of $8.0M.
Over the past 52 weeks VTGN has traded between $0.1600 and $5.14.
For the quarter ended Mar 31, 2026 it reported a net loss of $16.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$16.3M |
| Dec 31, 2025 | — | -$18.9M |
| Sep 30, 2025 | — | -$19.4M |
| Jun 30, 2025 | — | -$15.1M |
From Vistagen Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…